Hypertension, type IV cardiorenal syndrome and chronic kidney disease: Pathophysiological and therapeutical approach

doi:10.5494/wjh.v7.i1.10

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (16611)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

806

WORD

418

HTML

8312

Figures (1-2)

445

Tables (1-1)

267

Sum=10248

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

1443

Download

2104

Sum=3547

Publishing Process of This Article

Item

Count

Browse

1199

Download

1617

Sum=2816

Feb 23, 2017 (publication date) through Dec 22, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hypertension

ISSN

2220-3168

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hypertens. Feb 23, 2017; 7(1): 10-18
Published online Feb 23, 2017. doi: 10.5494/wjh.v7.i1.10

Open in New Tab Full Size Figure Download Figure

Figure 1 Algorithm of hypertension treatment in chronic kidney disease proteinuric patients. ARB: Angiotension II receptor blockers; GFR: Glomerular filtration rate; CAD: Coronary artery disease.

Open in New Tab Full Size Figure Download Figure

Figure 2 Pathophysiology of type IV cardiorenal syndrome. CKD: Chronic kidney disease.

Citation: Di Lullo L, Bellasi A, De Pascalis A. Hypertension, type IV cardiorenal syndrome and chronic kidney disease: Pathophysiological and therapeutical approach. World J Hypertens 2017; 7(1): 10-18
URL: https://www.wjgnet.com/2220-3168/full/v7/i1/10.htm
DOI: https://dx.doi.org/10.5494/wjh.v7.i1.10